المؤلفون: van Bentum, RE, Baniaamam, M, Kinaci-Tas, B, van de Kreeke, JA, Kocyigit, M, Tomassen, J, den Braber, A, Visser, PJ, ter Wee, MM, Serne, EH, Verbraak, FD, Nurmohamed, MT, van der Horst-Bruinsma, IE

المصدر: Seminars in arthritis and rheumatism. 50(6):1535-1541

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145551174

المؤلفون: van Bentum RE; R.E. van Bentum, MD, I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam; Irene.vanderHorst-Bruinsma@radboudumc.nl., Verbraak FD; F.D. Verbraak, MD, PhD, H.S. Tan, MD, PhD, Department of Ophthalmology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam., Wolf S; S. Wolf, MD, Department of Ophthalmology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, and Department of Ophthalmology, Bergman Clinics, Zaandam., Ongkosuwito J; J. Ongkosuwito, MD, PhD, Department of Ophthalmology, Onze Lieve Vrouwe Gasthuis, Amsterdam., Boers M; M. Boers, MD, PhD, Department of Rheumatology, and Department of Epidemiology & Data Science, Amsterdam Public Health, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, the Netherlands., Tan HS; F.D. Verbraak, MD, PhD, H.S. Tan, MD, PhD, Department of Ophthalmology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam., van der Horst-Bruinsma IE; R.E. van Bentum, MD, I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam.

المصدر: The Journal of rheumatology [J Rheumatol] 2022 Jul; Vol. 49 (7), pp. 680-687. Date of Electronic Publication: 2022 Feb 15.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Axial Spondyloarthritis* , Spondylarthritis*/complications , Spondylarthritis*/diagnosis , Spondylarthritis*/epidemiology , Spondylitis, Ankylosing*/complications , Uveitis, Anterior*/complications , Uveitis, Anterior*/diagnosis , Uveitis, Anterior*/epidemiology, Acute Disease ; Adult ; Back Pain/epidemiology ; Back Pain/etiology ; Delayed Diagnosis/adverse effects ; Female ; HLA-B27 Antigen ; Humans ; Male ; Middle Aged ; Prevalence ; Referral and Consultation

المؤلفون: van der Horst-Bruinsma IE; Department of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands., van Bentum RE; Department of Rheumatology, Amsterdam University Medical Centers, Location VU Medical Centre, Amsterdam, The Netherlands., Verbraak FD; Department of Ophthalmology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Deodhar A; Division of Arthritis and Rheumatic Diseases, Oregon Health and Science University, Portland, OR, USA., Rath T; Department of Opthalmology, St Franziskus-Hospital, Münster, Germany., Hoepken B; UCB Pharma, Monheim am Rhein, Germany., Irvin-Sellers O; UCB Pharma, Slough, UK., Thomas K; UCB Pharma, Monheim am Rhein, Germany., Bauer L; UCB Pharma, Monheim am Rhein, Germany., Rudwaleit M; Clinic for Internal Medicine and Rheumatology, Klinikum Bielefeld and Department of Gastroenterology, Infectiology and Rheumatology, Charité Berlin, Germany.

المصدر: Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2021 Mar 29; Vol. 13, pp. 1759720X211003803. Date of Electronic Publication: 2021 Mar 29 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE

المؤلفون: Van Bentum RE; Departments of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands., Van den Berg JM; Departments of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands.; Departments of Ophthalmology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands., Wolf SE; Departments of Ophthalmology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands.; Department of Ophthalmology, Bergman Clinics, Location Zaandam, the Netherlands., Van der Bijl J; Departments of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands., Tan HS; Departments of Ophthalmology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands., Verbraak FD; Departments of Ophthalmology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands., van der Horst-Bruinsma IE; Departments of Rheumatology, Amsterdam University Medical Center, Location VU Medical Center, Amsterdam, the Netherlands.

المصدر: Acta ophthalmologica [Acta Ophthalmol] 2021 Mar; Vol. 99 (2), pp. e164-e170. Date of Electronic Publication: 2020 Aug 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Disease Management* , Ophthalmologists* , Rheumatologists*, Autoimmune Diseases/*therapy , Eye Diseases/*therapy , Immunosuppression Therapy/*methods, Eye Diseases/immunology ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Retrospective Studies

المؤلفون: van Bentum RE; R.E. van Bentum, MD, T.R. Rusman, MSc, I.E. van der Horst-Bruinsma, MD, PhD, Professor, Department of Rheumatology, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, the Netherlands., Ibáñez Vodnizza SE; S.E. Ibáñez Vodnizza, MD, M.P. Poblete de la Fuente, MD, F. Valenzuela Aldridge, MD, O. Valenzuela Letelier, MD, Department of Rheumatology, Clínica Alemana - UDD Medicine Faculty, Santiago, Chile., Poblete de la Fuente MP; S.E. Ibáñez Vodnizza, MD, M.P. Poblete de la Fuente, MD, F. Valenzuela Aldridge, MD, O. Valenzuela Letelier, MD, Department of Rheumatology, Clínica Alemana - UDD Medicine Faculty, Santiago, Chile., Valenzuela Aldridge F; S.E. Ibáñez Vodnizza, MD, M.P. Poblete de la Fuente, MD, F. Valenzuela Aldridge, MD, O. Valenzuela Letelier, MD, Department of Rheumatology, Clínica Alemana - UDD Medicine Faculty, Santiago, Chile., Navarro-Compán V; V. Navarro-Compán, MD, PhD, Department of Rheumatology, University Hospital La Paz, IdiPaz, Madrid, Spain., Rusman TR; R.E. van Bentum, MD, T.R. Rusman, MSc, I.E. van der Horst-Bruinsma, MD, PhD, Professor, Department of Rheumatology, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, the Netherlands., Ter Wee MM; M.M. ter Wee, PhD, Department of Rheumatology, Amsterdam University Medical Centre, Vrije Universiteit, and Department of Epidemiology & Biostatistics, Amsterdam Public Health, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam., Valenzuela Letelier O; S.E. Ibáñez Vodnizza, MD, M.P. Poblete de la Fuente, MD, F. Valenzuela Aldridge, MD, O. Valenzuela Letelier, MD, Department of Rheumatology, Clínica Alemana - UDD Medicine Faculty, Santiago, Chile., van Weely SFE; S.F. van Weely, PhD, Department of Orthopedics, Rehabilitation and Physical Therapy, Leiden University Medical Centre, Leiden, the Netherlands., van der Horst-Bruinsma IE; R.E. van Bentum, MD, T.R. Rusman, MSc, I.E. van der Horst-Bruinsma, MD, PhD, Professor, Department of Rheumatology, Amsterdam University Medical Centre, Vrije Universiteit, Amsterdam, the Netherlands; ie.vanderhorst@amsterdamumc.nl.

المصدر: The Journal of rheumatology [J Rheumatol] 2020 Oct 01; Vol. 47 (10), pp. 1475-1482. Date of Electronic Publication: 2020 Feb 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Spondylarthritis* , Spondylitis, Ankylosing*/diagnostic imaging, Feasibility Studies ; Female ; Humans ; Male ; Reproducibility of Results ; Severity of Illness Index

المؤلفون: Rusman T; Department of Rheumatology, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands., van Bentum RE; Department of Rheumatology, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands., van der Horst-Bruinsma IE; Department of Rheumatology, Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.

المصدر: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Oct 01; Vol. 59 (Suppl4), pp. iv38-iv46.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE

مواضيع طبية MeSH: Spondylarthritis/*diagnosis, Anti-Inflammatory Agents/therapeutic use ; Disease Progression ; Female ; Humans ; Male ; Risk Factors ; Sex Factors ; Spondylarthritis/drug therapy ; Spondylarthritis/etiology ; Spondylarthritis/pathology ; Treatment Outcome

المؤلفون: Ibáñez Vodnizza SE; Department of Rheumatology, Clínica Alemana, Universidad del Desarrollo medicine Faculty, 1410, Av. Manquehue Norte, 7650567 Vitacura, Santiago, Chile. Electronic address: sibanez@alemana.cl., van Bentum RE; Department of Rheumatology, Amsterdam University Medical Center, location VUmc, 1117, De Boelelaan, 1081HV Amsterdam, Netherlands., Valenzuela O; Department of Rheumatology, Clínica Alemana, Universidad del Desarrollo medicine Faculty, 1410, Av. Manquehue Norte, 7650567 Vitacura, Santiago, Chile., van der Horst-Bruinsma IE; Department of Rheumatology, Amsterdam University Medical Center, location VUmc, 1117, De Boelelaan, 1081HV Amsterdam, Netherlands.

المصدر: Joint bone spine [Joint Bone Spine] 2020 Jul; Vol. 87 (4), pp. 315-319. Date of Electronic Publication: 2020 Feb 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Elsevier Country of Publication: France NLM ID: 100938016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1778-7254 (Electronic) Linking ISSN: 1297319X NLM ISO Abbreviation: Joint Bone Spine Subsets: MEDLINE

مواضيع طبية MeSH: Spondylarthritis*/diagnosis , Spondylarthritis*/drug therapy , Spondylarthritis*/epidemiology, Absenteeism ; Cross-Sectional Studies ; Female ; Humans ; Male ; Presenteeism ; Severity of Illness Index ; Surveys and Questionnaires

المؤلفون: van Bentum RE; Department of Rheumatology, Amsterdam University Medical Centre - Location VU University Medical Centre, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands., van der Horst-Bruinsma IE; Department of Rheumatology, Amsterdam University Medical Centre - Location VU University Medical Centre, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands. Electronic address: ie.vanderhorst@amsterdamumc.nl.

المصدر: Rheumatic diseases clinics of North America [Rheum Dis Clin North Am] 2020 May; Vol. 46 (2), pp. 367-378.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 8708093 Publication Model: Print Cited Medium: Internet ISSN: 1558-3163 (Electronic) Linking ISSN: 0889857X NLM ISO Abbreviation: Rheum Dis Clin North Am Subsets: MEDLINE

مواضيع طبية MeSH: Precision Medicine/*methods , Spondylarthritis/*drug therapy, Anti-Inflammatory Agents/therapeutic use ; Biological Products/therapeutic use ; Drug Tapering ; Humans ; Spondylarthritis/complications

المؤلفون: van Bentum RE; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Heslinga SC; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Nurmohamed MT; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Gerards AH; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Griep EN; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Koehorst CBJM; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Kok MR; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Schilder AM; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., Verhoef M; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center., van der Horst-Bruinsma IE; From the Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center, Amsterdam; Department of Rheumatology, Franciscus Vlietland Hospital, Schiedam; Department of Rheumatology, Antonius Hospital, Sneek; Department of Rheumatology, Gelre Hospital, Apeldoorn; Department of Rheumatology, Maasstad Hospital, Rotterdam; Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden; Department of Immunology, Merck Sharp & Dohme (MSD), Haarlem, the Netherlands. ie.vanderhorst@vumc.nl.; R.E. van Bentum, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; S.C. Heslinga, MD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; M.T. Nurmohamed, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, locations Reade and VU University Medical Center; A.H. Gerards, MD, Department of Rheumatology, Franciscus Vlietland Hospital; E.N. Griep, MD, PhD, Department of Rheumatology, Antonius Hospital; C.B. Koehorst, MD, Department of Rheumatology, Gelre Hospital; M.R. Kok, MD, PhD, Department of Rheumatology, Maasstad Hospital; A.M. Schilder, MD, Department of Rheumatology, Medical Centre Leeuwarden; M. Verhoef, MSc, Department of Immunology, MSD, the Netherlands; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, Amsterdam Rheumatology and immunology Center, locations Reade and VU University Medical Center. ie.vanderhorst@vumc.nl.

المصدر: The Journal of rheumatology [J Rheumatol] 2019 Feb; Vol. 46 (2), pp. 153-159. Date of Electronic Publication: 2018 Nov 01.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0315-162X (Print) Linking ISSN: 0315162X NLM ISO Abbreviation: J Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antirheumatic Agents/*therapeutic use , Immunologic Factors/*therapeutic use , Spondylitis, Ankylosing/*drug therapy , Uveitis, Anterior/*epidemiology, Acute Disease ; Adult ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacology ; Antirheumatic Agents/adverse effects ; Antirheumatic Agents/pharmacology ; Female ; Follow-Up Studies ; Humans ; Immunologic Factors/adverse effects ; Immunologic Factors/pharmacology ; Incidence ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors